| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Internal Medicine and Interdisciplinary Program in Immunology, University of Iowa College of Medicine, Iowa City, IA 52242
Both extracellular signal-regulated kinase (ERK) and c-Jun NH2-terminal kinase (JNK) have been implicated in mediating the signaling events that precede apoptosis. We studied the activation of these kinases during apoptosis of WEHI 231 B cells. Surface IgM ligation induces apoptosis of WEHI 231 cells. This effect is augmented by simultaneous engagement of CD95 and is inhibited by costimulation with either CD40 or IL-4R. We determined that surface IgM ligation activates ERK2 to a much greater level than JNK, and that IgM-mediated ERK2 activation is enhanced by costimulation with anti-CD95. Costimulation with either IL-4 or anti-CD40 interferes with anti-IgM-stimulated ERK2 activation. Transient expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) inhibits both ERK2 activation and cell death following stimulation with anti-IgM and the combination of anti-IgM plus anti-CD95. CD40 engagement alone activates JNK, but IL-4 stimulation does not. N-acetyl-L-cysteine pretreatment, which blocks CD40-mediated JNK activation, does not affect the ability of CD40 to inhibit anti-IgM-mediated ERK2 activation and apoptosis. Together, these data suggest that JNK activation is not required for CD40 inhibition of surface IgM-induced cell death and that ERK2 plays an active role in mediating anti-IgM-induced apoptosis of WEHI 231 B cells.
This article has been cited by other articles:
|
|
 |
|
  F. Guo, C. S. Velu, H. L. Grimes, and Y. Zheng Rho GTPase Cdc42 is essential for B-lymphocyte development and activation Blood, October 1, 2009; 114(14): 2909 - 2916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. O. Lobo, Z. Zhang, and J. E. Shively Pivotal Advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner J. Leukoc. Biol., August 1, 2009; 86(2): 205 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Ha, Y.-C. Mun, C.-M. Seong, and J. R. Lee Characterization of phenotypically distinct B-cell subsets and receptor-stimulated mitogen-activated protein kinase activation in human cord blood B cells J. Leukoc. Biol., December 1, 2008; 84(6): 1557 - 1564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ivanov, S. Krysov, M. S. Cragg, and T. Illidge Radiation Therapy with Tositumomab (B1) Anti-CD20 Monoclonal Antibody Initiates Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase-Dependent Cell Death that Overcomes Resistance to Apoptosis Clin. Cancer Res., August 1, 2008; 14(15): 4925 - 4934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ke, M. Gururajan, A. Kumar, A. Simmons, L. Turcios, R. L. Chelvarajan, D. M. Cohen, D. L. Wiest, J. G. Monroe, and S. Bondada The Role of MAPKs in B Cell Receptor-induced Down-regulation of Egr-1 in Immature B Lymphoma Cells J. Biol. Chem., December 29, 2006; 281(52): 39806 - 39818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Poggianella, M. Bestagno, and O. R. Burrone The Extracellular Membrane-Proximal Domain of Human Membrane IgE Controls Apoptotic Signaling of the B Cell Receptor in the Mature B Cell Line A20 J. Immunol., September 15, 2006; 177(6): 3597 - 3605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Herrin, A. L. Groeger, and L. B. Justement The Adaptor Protein HSH2 Attenuates Apoptosis in Response to Ligation of the B Cell Antigen Receptor Complex on the B Lymphoma Cell Line, WEHI-231 J. Biol. Chem., February 4, 2005; 280(5): 3507 - 3515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Chiles Regulation and Function of Cyclin D2 in B Lymphocyte Subsets J. Immunol., September 1, 2004; 173(5): 2901 - 2907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Guilbault and R. J. Kay RasGRP1 Sensitizes an Immature B Cell Line to Antigen Receptor-induced Apoptosis J. Biol. Chem., May 7, 2004; 279(19): 19523 - 19530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Ha and J. R. Lee Role of TNF Receptor-Associated Factor 3 in the CD40 Signaling by Production of Reactive Oxygen Species through Association with p40phox, a Cytosolic Subunit of Nicotinamide Adenine Dinucleotide Phosphate Oxidase J. Immunol., January 1, 2004; 172(1): 231 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen, K. Alm, S. Vujcic, D. L. Kramer, K. Kee, P. Diegelman, and C. W. Porter The Role of Mitogen-activated Protein Kinase Activation in Determining Cellular Outcomes in Polyamine Analogue-treated Human Melanoma Cells Cancer Res., July 1, 2003; 63(13): 3619 - 3625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-K. Yi, J.-G. Yoon, and A. M. Krieg Convergence of CpG DNA- and BCR-mediated signals at the c-Jun N-terminal kinase and NF-{kappa}B activation pathways: regulation by mitogen-activated protein kinases Int. Immunol., May 1, 2003; 15(5): 577 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Mizuno, Y. Tagawa, K. Mitomo, N. Watanabe, T. Katagiri, M. Ogimoto, and H. Yakura Src Homology Region 2 Domain-Containing Phosphatase 1 Positively Regulates B Cell Receptor-Induced Apoptosis by Modulating Association of B Cell Linker Protein with Nck and Activation of c-Jun NH2-Terminal Kinase J. Immunol., July 15, 2002; 169(2): 778 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Gauld, D. Blair, C. A. Moss, S. D. Reid, and M. M. Harnett Differential Roles for Extracellularly Regulated Kinase-Mitogen-Activated Protein Kinase in B Cell Antigen Receptor-Induced Apoptosis and CD40-Mediated Rescue of WEHI-231 Immature B Cells J. Immunol., April 15, 2002; 168(8): 3855 - 3864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Richards, S. H. Dave, C.-H. G. Chou, A. A. Mamchak, and A. L. DeFranco Inhibition of the MEK/ERK Signaling Pathway Blocks a Subset of B Cell Responses to Antigen J. Immunol., March 15, 2001; 166(6): 3855 - 3864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Takada, H. Toyota, J. Suzuki, and J. Mizuguchi Prevention of Anti-IgM-Induced Apoptosis Accompanying G1 Arrest in B Lymphoma Cells Overexpressing Dominant-Negative Mutant Form of c-Jun N-Terminal Kinase 1 J. Immunol., February 1, 2001; 166(3): 1641 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Sen, S. Khanna, S. Roy, and L. Packer Molecular Basis of Vitamin E Action. TOCOTRIENOL POTENTLY INHIBITS GLUTAMATE-INDUCED pp60c-Src KINASE ACTIVATION AND DEATH OF HT4 NEURONAL CELLS J. Biol. Chem., April 21, 2000; 275(17): 13049 - 13055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Swart, D. M. Bergeron, and T. C. Chiles Identification of a Membrane Ig-Induced p38 Mitogen-Activated Protein Kinase Module That Regulates cAMP Response Element Binding Protein Phosphorylation and Transcriptional Activation in CH31 B Cell Lymphomas J. Immunol., March 1, 2000; 164(5): 2311 - 2319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-Y. Cao, F. Shinjo, S. Heinrichs, J.-W. Soh, J. Jongstra-Bilen, and J. Jongstra Inhibition of Anti-IgM-induced Translocation of Protein Kinase C beta I Inhibits ERK2 Activation and Increases Apoptosis J. Biol. Chem., June 29, 2001; 276(27): 24506 - 24510. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
